ClearCut Medical today announced it appointed Hezi Himelfarb as CEO.
Himelfarb brings over 30 years of experience to the Israel-based portable MRI company. He most recently was CEO of O2Cure, which develops blood oxygenators from ECMO operation to artificial lung. Himelfarb has also served as general manager and chief operating officer at Microbot Medical, CEO of IceCure Medical and CEO of Remon Medical Technologies.
“ClearCut’s success to date has been driven by an incredibly strong team. As we prepare for the commercialization of our ClearCoast intra-operative MRI system, we are happy to be adding world-class med-tech executive who will lay the foundation for our future success. Hezi’s experience developing and commercializing innovative medical technologies in private and public companies is a perfect fit for ClearCut,” chairperson Mike Berman said in a news release.”His proven ability to build value in venture-backed companies and navigate regulatory, reimbursement and early market commercialization environments will be an invaluable asset.”
Himelfarb said he thinks ClearCut’s ClearCoast System is poised to make an impact on cancer surgery and clinical pathology.
Said Himelfarb: “The team has done a phenomenal job developing and clinically testing this important breakthrough in MRI technology form factor, and in establishing strong clinical and strategic relationships that will be the basis for global adoption starting with the European launch this year.”
